Yuvaansh Pharma

Dolutegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg Tablets are a fixed-dose combination used for the treatment of HIV-1 infection. Dolutegravir is an integrase inhibitor, while Emtricitabine and Tenofovir Alafenamide are nucleoside reverse transcriptase inhibitors (NRTIs). Together, they block HIV replication in the body. Taken once daily, this combination helps reduce viral load and increase CD4 cell count. Regular monitoring is advised during treatment.

Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate 300 mg Tablets IP are antiretroviral medications used in combination to treat HIV-1 infection and for HIV pre-exposure prophylaxis (PrEP). Both drugs are nucleoside reverse transcriptase inhibitors (NRTIs) that work together to block HIV replication. Taken once daily, with or without food, they help reduce viral load and prevent disease progression. Regular monitoring of kidney function and bone health is advised during use.

• Lazid Tablet is a combination of two antiretrovirals. It is prescribed to treat HIV (human immunodeficiency virus) infection. It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome).
• Lazid Tablet restricts the growth of HIV in the body and reduces the risk of getting HIV-related complications to improve the lifespan of an individual. The medicine can be taken with or without food. Taking these medicines regularly at the same time increases their effectiveness. A dose of this medicine should not be missed as it can affect your recovery. It is important to complete the full course of the treatment until your doctor advises you to stop it.

The amount of Tacrograf 0.25 Capsule you take and how often you take it depends on the type of transplant you have, your body weight, and what other medicines you are taking. Follow your doctor’s instructions carefully. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Take this medicine regularly to get the maximum benefit and keep taking it, even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ.

Trastuzumab Injection 440 mg is a monoclonal antibody used for treating HER2-positive breast cancer and certain gastric cancers. It targets the HER2 protein on cancer cells, blocking their growth and signaling for destruction. Given by intravenous infusion under medical supervision, dosing depends on treatment protocols. Regular monitoring of heart function and infusion reactions is essential to ensure safety during therapy.